MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/500/0.01/21.06.24 Stock

Warrant

DE000MD7LX96

Market Closed - Börse Stuttgart 14:15:28 2024-05-31 EDT
0.111 EUR -13.95% Intraday chart for MORGAN STANLEY PLC/CALL/IDEXX LABORATORIES/500/0.01/21.06.24
Current month-49.55%
1 month-49.55%
Date Price Change
24-05-31 0.111 -13.95%
24-05-30 0.129 -11.03%
24-05-29 0.145 -39.58%
24-05-28 0.24 +4.35%
24-05-27 0.23 -23.33%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 02:15 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying IDEXX LABORATORIES, INC.
Issuer Morgan Stanley
WKN MD7LX9
ISINDE000MD7LX96
Date issued 2022-08-30
Strike 500 $
Maturity 2024-06-21 (20 Days)
Parity 100 : 1
Emission price 0.13
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.11
Lowest since issue 0.101
Delta0.5x
Omega 17.04
Premium3.55x
Gearing34.06x
Moneyness 0.9939
Difference Strike 3.05 $
Difference Strike %+0.61%
Spread 0.023
Spread %15.75%
Theoretical value 0.1345
Implied Volatility 32.14 %
Total Loss Probability 53.04 %
Intrinsic value 0.000000
Present value 0.1345
Break even 514.59 €
Theta-0.03x
Vega0x
Rho0x

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).
Sector
-
More about the company

Ratings for IDEXX Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: IDEXX Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
497 USD
Average target price
563.8 USD
Spread / Average Target
+13.45%
Consensus